Lab-Grown mini tumors could predict chemo outcomes for breast cancer patients
NCT ID NCT07260188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study takes small tumor samples from 240 women with invasive breast cancer who are scheduled for chemotherapy before surgery. Researchers will grow these samples into mini-tumors (organoids) in the lab to study each cancer's unique features. The goal is to see if these lab models can predict whether the cancer will completely disappear after chemotherapy, and to find new biomarkers that could guide personalized treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituti Clinici Scientifici Maugeri
RECRUITINGPavia, PV, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can sound waves replace the scalpel for breast tumors?
- Could a bank of breast cancer samples unlock new treatments?
- Less radiation for breast cancer? a trial tests a smarter, response-based approach
- Proton beam aims to spare healthy tissue after breast cancer surgery
- Can walking flush out hidden toxins? new study tests exercise against PFAS